AMIRREZA SOLHPOUR to Treatment Outcome
This is a "connection" page, showing publications AMIRREZA SOLHPOUR has written about Treatment Outcome.
Connection Strength
0.103
-
Ischemic time is a better predictor than door-to-balloon time for mortality and infarct size in ST-elevation myocardial infarction. Catheter Cardiovasc Interv. 2016 Jun; 87(7):1194-200.
Score: 0.030
-
Fibrinolytic therapy in patients with ST-elevation myocardial infarction. Expert Rev Cardiovasc Ther. 2014 Feb; 12(2):201-15.
Score: 0.027
-
Comparison of outcomes for patients =75 years of age treated with pre-hospital reduced-dose fibrinolysis followed by percutaneous coronary intervention versus percutaneous coronary intervention alone for treatment of ST-elevation myocardial infarction. Am J Cardiol. 2014 Jan 01; 113(1):60-3.
Score: 0.026
-
Comparison of in-hospital outcomes with low-dose fibrinolytic therapy followed by urgent percutaneous coronary intervention versus percutaneous coronary intervention alone for treatment of ST-elevation myocardial infarction. Am J Cardiol. 2013 Jun 01; 111(11):1576-9.
Score: 0.006
-
Cardiovascular death in dialysis patients: lessons we can learn from AURORA. Clin J Am Soc Nephrol. 2010 Feb; 5(2):335-40.
Score: 0.005
-
Randomized trial of pimecrolimus cream versus triamcinolone acetonide paste in the treatment of oral lichen planus. J Am Acad Dermatol. 2007 Nov; 57(5):806-13.
Score: 0.004
-
Pimecrolimus cream, 1%, vs hydrocortisone acetate cream, 1%, in the treatment of facial seborrheic dermatitis: a randomized, investigator-blind, clinical trial. Arch Dermatol. 2006 Aug; 142(8):1066-7.
Score: 0.004